IMMUDAPTIN

Welcome to the Brand page for “IMMUDAPTIN”, which is offered here for Pharmaceuticals, immunotherapeutic agents for the treatment of infectious diseases including viral, bacterial and parasitic infections such as malaria, inflammatory and autoimmune diseases including arthritis, psoriasis and vasculitis and reperfusion injury, cardiovascular diseases including atherosclerosis and stroke, neurodegenerative disorders such as alzheimer's disease and metabolic diseases such as diabetes; pharmaceuticals, polypeptides for the treatment of the aforesaid diseases and disorders; pharmaceuticals, vaccines incorporating molecular adjuvants for the prevention and treatment of the aforesaid diseases, disorders and cancer; veterinary preparations for the treatment of infectious and parasitic diseases inflammatory diseases and cancer in pets and infectious and parasitic diseases in livestock;medical and scientific research services relating to discovery, development or improvement of chemical, medical and veterinary preparations; medical and scientific research services relating to modification of pharmaceutically useful molecules, protein therapeutic agents and polypeptides, immunotherapeutic agents, molecular adjuvants and vaccines;.

Its status is currently believed to be active. Its class is unavailable. “IMMUDAPTIN” is believed to be currently owned by “ADPROTECH LIMITED”.